News Focus
News Focus
icon url

Waverunner1

08/23/15 5:17 PM

#119742 RE: BioHedge #119737

All QE did was balance supply with the huge demand globally for safe assets in the form of US dollars. That was quite necessary but arguably no longer needed as risk aversion has been slowly but steadily fading. Just look at the growth in the level of C&I loans here in the U.S. Either way, stock performance related to clinical trial success for biotechs like CTIX is largely impervious to such macro gyrations.


Good points but QE has caused all kinds of distortions in the markets - credit spreads being the most affected.



My last post of the day so this is for Sunspotter:

You seem to be attaching zero sigificance to B's unique MOA. Yes, of course it must be proven over time. But lets talk about the large increase in odds against resistance developing with the unique MOA. That clearly sets Brilacidin apart from the other AB's out there but for some reason seems to be completely lost on you.